⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30484487 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL6898023 | 0.97 | — | — | |
| Bromide SCHEMBL2552778 | 0.97 | — | — | |
| SCHEMBL30313392 | 0.72 | — | — | |
| SCHEMBL2814353 | 0.69 | HSP90AA1 (0.52) | — | |
| SCHEMBL30595872 | 0.69 | HSP90AA1 (0.52) | — | |
| Pyrimidine SCHEMBL2651374 | 0.69 | KDM4E (0.40) | — | |
| Potassium Ion SCHEMBL11164216 | 0.69 | — | — | |
| SCHEMBL11230707 | 0.69 | — | — | |
| Water SCHEMBL28281553 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 316 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119462628-A | RAR PROTAC compound, pharmaceutical composition, preparation method and application | 湖北大学 | 2025-02-18 | — | — | CN | claimed |
| CN-118146210-A | Organic molecular additive and preparation method and application thereof | 正泰新能科技股份有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-117402289-A | Room-temperature phosphorescent material of polyacrylamide copolymer containing biaryl compound and preparation method thereof | 广东工业大学 | 2024-01-16 | — | — | CN | claimed |
| CN-107739368-A | N substitutions 5（（The base of 4 substituted pyrimidines 2）Amino）Indole derivatives and its production and use | 厦门大学 | 2018-02-27 | — | — | CN | claimed |
| CN-106543090-A | The synthetic method of 4 bromine of medical body, 2 methyl, 3,6 dihydroxy-pyrimidine | 无锡乾浩生物医药有限公司 | 2017-03-29 | — | — | CN | claimed |
| US-20250276972-A1 | COMPOUNDS AS CASEIN KINASE INHIBITORS | GRITSCIENCE BIOPHARMACEUTICALS CO LTD (CN) | 2025-09-04 | — | — | US | disclosed |
| EP-4061813-B1 | PYRROLIDINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2025-06-04 | — | — | EP | disclosed |
| CN-120058708-A | Alkynyl alcohol derivative and medical application thereof | 中国药科大学 | 2025-05-30 | — | — | CN | disclosed |
| US-12312337-B2 | Compounds and methods for treating cancer | ANTIDOTE IP HOLDINGS, LLC (US) | 2025-05-27 | — | — | US | disclosed |
| CN-112384505-B | Therapeutic heterocyclic compounds | 吉利德科学公司 | 2025-05-27 | — | — | CN | disclosed |
| EP-4551570-A1 | NOVEL COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | Dong-A ST Co., Ltd. (KR) | 2025-05-14 | — | — | EP | disclosed |
| EP-4541422-A2 | QUINOLINE DERIVATIVES AS ALPHA4BETA7 INTEGRIN INHIBITORS | Gilead Sciences, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| US-20020198195-A1 | New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2002-12-26 | — | — | US | disclosed |
| WO-2002051831-A1 | OXYBENZAMIDES DERIVATIVES AS FACTOR XA INHIBITORS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-07-04 | — | — | WO | disclosed |
| EP-1217000-A1 | Inhibitors of factor Xa and factor VIIa | Aventis Pharma Deutschland GmbH (DE) | 2002-06-26 | — | — | EP | disclosed |
| WO-2001085861-A1 | ACTIVATOR COMPOSITIONS FOR CYANOACRYLATE ADHESIVES | LOCTITE (R & D) LIMITED (IE) | 2001-11-15 | — | — | WO | disclosed |
| EP-0476645-B1 | Calcium uptake inhibitors | MERRELL DOW PHARMA (US) | 1995-09-06 | — | — | EP | disclosed |
| US-5409942-A | Administering 1-phenyl-3-aryl-2-propyne-1-ones compounds | MERRELL DOW PHARMACEUTICALS INC. (US) | 1995-04-25 | — | — | US | disclosed |
| US-5223518-A | Controlling intake in leukocytes and platelets | MERRELL DOW PHARMACEUTICALS INC. (US) | 1993-06-29 | — | — | US | disclosed |
| EP-0476645-A1 | Calcium uptake inhibitors | MERRELL DOW PHARMACEUTICALS INC. (US) | 1992-03-25 | — | — | EP | disclosed |